GRPR and Alzheimer disease: Since previous clinical studies in the fields ofgastroenterology and oncology have indicated that BLPs and RC-3095 do not induceovert side effects when administered intravenously in humans,42,43 clinical trials evaluating the effects of drugs acting atthe GRPR on cognitive function in patients with AD and other neurodegenerative andpsychiatric disorders are warranted.